Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis
Authors:
- 10 April 2017
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 36 (6) , 1317-1324
Abstract
TL1A is a member of the TNF superfamily. It performs significantly in the pathogenesis of rheumatic and autoimmune diseases partly through regulating the Th17 pathway. The clinical implication of circulating TL1A in patients with systemic sclerosis (SSc) remains unclear, and correlation between TL1A and Th17-related cytokines in the pathogenesis of SSc needs to be discussed. We measured serum levels of TL1A and Th17-related cytokines by ELISA in 47 patients with SSc, 56 patients with SLE, and 53 healthy subjects, and investigated association of these cytokines with clinical manifestations and laboratory variables. TL1A in relation to Th17-related cytokines were examined. In addition, the transcript level of TL1A in peripheral blood mononuclear cells (PBMCs) was determined by real-time reverse transcription polymerase chain reaction (real-time PCR). Serum TL1A levels were higher in patients with SSc than in healthy controls (P = 0.001), but were lower compared with SLE patients (P = 0.004). Diffuse cutaneous SSc or limited cutaneous SSc patients reported elevated expression of TL1A than those in healthy controls (P = 0.002, P = 0.007). Patients with active disease showed significantly higher expression of TL1A when compared with less active disease (P = 0.014). SSc patients with arthritis, elevated IgG titer, ESR >30 mm/h, and CRP >5 mg/l displayed elevated expression of TL1A, respectively. Serum levels of IL-17 and IL-21 were increased in SSc patients compared with healthy controls and positively related to TL1A levels (r s = 0.373, P = 0.010; r s = 0.370, P = 0.011, respectively). Moreover, TL1A mRNA expression in PBMCs was significantly higher in patients with SSc compared with healthy controls (P < 0.001). TL1A may play a role in the development of SSc.Keywords
Funding Information
- Sichuan Provincial Health and Family Planning Commission (16PJ284)
- Specialized Research Fund for the Doctoral Program of Higher Education of China (20120181110009)
This publication has 31 references indexed in Scilit:
- TL1A as a Potential Local Inducer of IL17A Expression in Colon Mucosa of Inflammatory Bowel Disease PatientsScandinavian Journal of Immunology, 2015
- Elevated plasma levels of TL1A in newly diagnosed systemic lupus erythematosus patientsRheumatology International, 2015
- Serum and synovial fluid levels of tumor necrosis factor-like ligand 1A and decoy receptor 3 in rheumatoid arthritisCytokine, 2015
- Elevated frequencies of CD4+IL‐21+T, CD4+IL‐21R+T and IL‐21+Th17 cells, and increased levels of IL‐21 in bleomycin‐induced mice may be associated with dermal and pulmonary inflammation and fibrosisInternational Journal of Rheumatic Diseases, 2014
- High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel DiseaseMediators of Inflammation, 2013
- Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-γ, in mucosal inflammationClinical Immunology, 2004
- TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-γ Production in Human T Cells and NK CellsThe Journal of Immunology, 2004
- European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteriaAnnals of the Rheumatic Diseases, 2003
- TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell CostimulatorImmunity, 2002
- Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.1993